Literature DB >> 8457880

Dorsal and ventral dopaminergic innervation of the spinal cord: functional implications.

J Weil-Fugazza1, F Godefroy.   

Abstract

Several studies have demonstrated that a descending dopaminergic pathway innervates the dorsal and the intermediate gray matter of the spinal cord and have suggested that this pathway is involved in pain modulation and in the control of autonomic functions. Other studies have also demonstrated the presence of dopamine (DA) and DA metabolites as well as of DA receptors in the ventral cord. There is also evidence for the implication of DA in the control of motor functions at the spinal level. The occurrence of a dopaminergic innervation in the ventral horn has been, however, disputed until recently. But recent work has demonstrated that the motoneural cell groups in the ventral horn (lamina IX) are a target for descending dopaminergic fibers. In addition, the possibility that DA is a mediator of primary afferent fibers has also been postulated. Finally, the occurrence of dopaminergic cell bodies has been suggested in the spinal cord. This indicates that DA is probably implicated in a complex manner in spinal functions. In the present paper the possible involvement of DA in sensory and in motor functions at spinal level will be discussed in view of neurochemical observations made in polyarthritic rats, in which pain-related behavior and reduction of locomotor activity associated with a marked decrease in mobility, are observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457880     DOI: 10.1016/0361-9230(93)90259-e

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  8 in total

1.  Dopaminergic modulation of locomotor network activity in the neonatal mouse spinal cord.

Authors:  Simon A Sharples; Jennifer M Humphreys; A Marley Jensen; Sunny Dhoopar; Nicole Delaloye; Stefan Clemens; Patrick J Whelan
Journal:  J Neurophysiol       Date:  2015-02-04       Impact factor: 2.714

2.  Neuroanatomical study of the A11 diencephalospinal pathway in the non-human primate.

Authors:  Quentin Barraud; Ibrahim Obeid; Incarnation Aubert; Gregory Barrière; Hugues Contamin; Steve McGuire; Paula Ravenscroft; Gregory Porras; François Tison; Erwan Bezard; Imad Ghorayeb
Journal:  PLoS One       Date:  2010-10-13       Impact factor: 3.240

3.  Dopamine as trace amine in the dorsal root ganglia.

Authors:  J Weil-Fugazza; B Onteniente; G Audet; E Philippe
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

4.  Stimulation of dopamine D2-like receptors in the lumbosacral defaecation centre causes propulsive colorectal contractions in rats.

Authors:  Kiyotada Naitou; Hiroyuki Nakamori; Takahiko Shiina; Azusa Ikeda; Yuuta Nozue; Yuuki Sano; Takuya Yokoyama; Yoshio Yamamoto; Akihiro Yamada; Nozomi Akimoto; Hidemasa Furue; Yasutake Shimizu
Journal:  J Physiol       Date:  2016-04-28       Impact factor: 5.182

5.  Critical role of calpain in spinal cord degeneration in Parkinson's disease.

Authors:  Supriti Samantaray; Varduhi H Knaryan; Donald C Shields; Naren L Banik
Journal:  J Neurochem       Date:  2013-08-20       Impact factor: 5.372

6.  Caffeine stimulates locomotor activity in the mammalian spinal cord via adenosine A1 receptor-dopamine D1 receptor interaction and PKA-dependent mechanisms.

Authors:  JeanMarie Acevedo; Alexandra Santana-Almansa; Nikol Matos-Vergara; Luis René Marrero-Cordero; Ernesto Cabezas-Bou; Manuel Díaz-Ríos
Journal:  Neuropharmacology       Date:  2015-10-19       Impact factor: 5.250

7.  Optogenetic Activation of A11 Region Increases Motor Activity.

Authors:  Kathrin Koblinger; Céline Jean-Xavier; Sandeep Sharma; Tamás Füzesi; Leanne Young; Shane E A Eaton; Charlie Hong Ting Kwok; Jaideep Singh Bains; Patrick J Whelan
Journal:  Front Neural Circuits       Date:  2018-10-11       Impact factor: 3.492

Review 8.  Restless Legs Syndrome and Parkinson Disease: A Causal Relationship Between the Two Disorders?

Authors:  Luigi Ferini-Strambi; Giulia Carli; Francesca Casoni; Andrea Galbiati
Journal:  Front Neurol       Date:  2018-07-24       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.